Arkolith/Insider Trading/ZVRA/Form 4

Bode John B

DirectorZEVRA THERAPEUTICS, INC. (ZVRA) · full profile →Form 4 · filed Mar 26, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 24, 2026Option exercise(M)39K$4.97$195K84K
Mar 24, 2026Option exercise(M)39K$4.89$192K123K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 24, 2026Option exercise(M)39K—$00
Mar 24, 2026Option exercise(M)39K—$020K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001612084-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for ZEVRA THERAPEUTICS, INC.

Build

Ask your agent about ZVRA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001612084-26-000002"
Ask your agent
Use Arkolith to summarize insider buying and selling at ZEVRA THERAPEUTICS, INC.
over the last 90 days and cite the filings.